Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

81 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Receptor-binding loops in alphacoronavirus adaptation and evolution.
Wong AHM, Tomlinson ACA, Zhou D, Satkunarajah M, Chen K, Sharon C, Desforges M, Talbot PJ, Rini JM. Wong AHM, et al. Among authors: sharon c. Nat Commun. 2017 Nov 23;8(1):1735. doi: 10.1038/s41467-017-01706-x. Nat Commun. 2017. PMID: 29170370 Free PMC article.
Immunogenicity of a receptor-binding domain of SARS coronavirus spike protein in mice: implications for a subunit vaccine.
Zakhartchouk AN, Sharon C, Satkunarajah M, Auperin T, Viswanathan S, Mutwiri G, Petric M, See RH, Brunham RC, Finlay BB, Cameron C, Kelvin DJ, Cochrane A, Rini JM, Babiuk LA. Zakhartchouk AN, et al. Among authors: sharon c. Vaccine. 2007 Jan 2;25(1):136-43. doi: 10.1016/j.vaccine.2006.06.084. Epub 2006 Aug 2. Vaccine. 2007. PMID: 16919855 Free PMC article.
Comparative evaluation of two severe acute respiratory syndrome (SARS) vaccine candidates in mice challenged with SARS coronavirus.
See RH, Zakhartchouk AN, Petric M, Lawrence DJ, Mok CPY, Hogan RJ, Rowe T, Zitzow LA, Karunakaran KP, Hitt MM, Graham FL, Prevec L, Mahony JB, Sharon C, Auperin TC, Rini JM, Tingle AJ, Scheifele DW, Skowronski DM, Patrick DM, Voss TG, Babiuk LA, Gauldie J, Roper RL, Brunham RC, Finlay BB. See RH, et al. Among authors: sharon c. J Gen Virol. 2006 Mar;87(Pt 3):641-650. doi: 10.1099/vir.0.81579-0. J Gen Virol. 2006. PMID: 16476986
Corrigendum to 'Long-term outcomes to neoadjuvant pembrolizumab based on pathological response for patients with resectable stage III/IV cutaneous melanoma': [Annals of Oncology 34 (2023) 806-812].
Sharon CE, Tortorello GN, Ma KL, Huang AC, Xu X, Giles LR, McGettigan S, Kreider K, Schuchter LM, Mathew AJ, Amaravadi RK, Gimotty PA, Miura JT, Karakousis GC, Mitchell TC. Sharon CE, et al. Ann Oncol. 2024 Apr 13:S0923-7534(24)00076-0. doi: 10.1016/j.annonc.2024.03.002. Online ahead of print. Ann Oncol. 2024. PMID: 38614876 No abstract available.
Pathologic characteristics and clinical outcomes of primary dermal melanoma.
Tortorello GN, Li EH, Sharon CE, Shafique N, Chu EY, Ming ME, Karakousis GC. Tortorello GN, et al. Among authors: sharon ce. J Am Acad Dermatol. 2024 Feb 23:S0190-9622(24)00401-8. doi: 10.1016/j.jaad.2024.01.082. Online ahead of print. J Am Acad Dermatol. 2024. PMID: 38401765 No abstract available.
Neoadjuvant therapy for resectable melanoma.
Sharon CE, Karakousis GC. Sharon CE, et al. Clin Exp Metastasis. 2024 Jan 28. doi: 10.1007/s10585-023-10263-1. Online ahead of print. Clin Exp Metastasis. 2024. PMID: 38281255 Review.
81 results